Cargando…
Good response of low-dose steroid in a patient with COVID-19 pneumonia and autoimmune disease
Autores principales: | Chang, Yea-Yuan, Wang, Wen-Hsiu, Ku, Stephane Wen-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114591/ https://www.ncbi.nlm.nih.gov/pubmed/34090821 http://dx.doi.org/10.1016/j.jmii.2021.04.005 |
Ejemplares similares
-
Low dose radiotherapy for COVID pneumonia: Irradiate to Eradicate – Will it be possible?
por: Deokar, Kunal, et al.
Publicado: (2021) -
High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021) -
Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020) -
Author response to “lack of benefit from low dose computed tomography in screening for lung cancer”
por: Huang, Kai-Lin, et al.
Publicado: (2020) -
Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012)